T-group (topology)
2006.1.3 Toprim domain
Ligands and drugs
2,188
Member domains
321
with ligand contacts (≤ 4 Å)
14.7% of members
253
with DrugDomain annotations
11.6% of members
116
with a DrugBank compound
5.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2006.1.3 belongs to X-group 2006 HAD domain-like, which binds 9.7 ligand superclasses per 20 proteins, broader than 91% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00218 | MFX | Moxifloxacin | 15 |
| DB00773 | EVP | Etoposide | 15 |
| DB01137 | LFX | Levofloxacin | 15 |
| DB00685 | TR6 | Trovafloxacin | 7 |
| DB00537 | CPF | Ciprofloxacin | 6 |
| DB00276 | ASW | Amsacrine | 3 |
| DB01204 | MIX | Mitoxantrone | 3 |
| DB08651 | TSP | 3'-THIO-THYMIDINE-5'-PHOSPHATE | 3 |
| DB00145 | GLY | Glycine | 2 |
| DB00380 | — | Dexrazoxane | 2 |
| DB00694 | — | Daunorubicin | 2 |
| DB00997 | — | Doxorubicin | 2 |
| DB01643 | TMP | Thymidine monophosphate | 2 |
| DB05022 | — | — | 2 |
| DB06362 | — | — | 2 |
| DB06421 | — | — | 2 |
| DB12817 | R8U | Zoliflodacin | 2 |
| DB00171 | ATP | ATP | 1 |
| DB00385 | — | — | 1 |
| DB00444 | — | Teniposide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 139 |
| MNmetal | MANGANESE (II) ION | 85 |
| EVP | (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside | 21 |
| MFX | 1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 16 |
| JK8 | (2~{R})-2-[[5-(2-chlorophenyl)-1,2-benzoxazol-3-yl]oxy]-2-phenyl-ethanamine | 14 |
| LFX | (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid | 14 |
| ZNmetal | ZINC ION | 12 |
| CL | CHLORIDE ION | 11 |
| TE9 | delafloxacin | 8 |
| CPF | 1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID | 7 |
| PDQ | 3-amino-7-{(3R)-3-[(1S)-1-aminoethyl]pyrrolidin-1-yl}-1-cyclopropyl-6-fluoro-8-methylquinazoline-2,4(1H,3H)-dione | 6 |
| TR6 | Trovafloxacin | 6 |
| TMP | THYMIDINE-5'-PHOSPHATE | 5 |
| 8MX | 1-cyclopropyl-6-fluoro-8-methyl-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 4 |
| 94H | ~{N}-[(1~{R})-2-azanyl-1-phenyl-ethyl]-4-(1~{H}-pyrrolo[2,3-b]pyridin-3-yl)thiophene-2-carboxamide | 4 |
| ASW | N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide | 4 |
| BEN | BENZAMIDINE | 4 |
| E32 | 7-[(3~{S})-3-azanylpyrrolidin-1-yl]-5-cyclopropyl-8-fluoranyl-imidazo[1,2-a]quinoxalin-4-one | 4 |
| GFN | 1-cyclopropyl-6-fluoro-8-methoxy-7-[(3S)-3-methylpiperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 4 |
| TNJ | 7-[(1S,5R)-1-amino-3-azabicyclo[3.1.0]hexan-3-yl]-4-(aminomethyl)-1-cyclopropyl-3,6-difluoro-8-methylquinolin-2(1H)-one | 4 |